Cleared Traditional

K203210 - Invacare Platinum 5NXG Oxygen Concentrator

K203210 is the FDA 510(k) clearance for Invacare Platinum 5NXG Oxygen Concentrator by Invacare Corporation. It is a Class 2 Anesthesiology device (product code CAW) cleared through the Traditional 510(k) pathway after a 164-day FDA review.

K203210 · Invacare Corporation · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2021
Decision
164d
Days
Class 2
Risk

K203210 is an FDA 510(k) clearance for the Invacare Platinum 5NXG Oxygen Concentrator. Classified as Generator, Oxygen, Portable within the CAW classification (a category for home-use oxygen therapy and respiratory devices), Class II - Special Controls.

Submitted by Invacare Corporation (Elyria, US). The FDA issued a Cleared decision on April 12, 2021 after a review of 164 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5440 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Invacare Corporation devices

Submission Details

510(k) Number K203210 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 30, 2020
Decision Date April 12, 2021
Days to Decision 164 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d slower than avg
Panel avg: 140d · This submission: 164d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CAW Generator, Oxygen, Portable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAW Generator, Oxygen, Portable

All 75
Devices cleared under the same product code (CAW) and FDA review panel - the closest regulatory comparables to K203210.
Oxygen Concentrator, Model JAY-5AW
K213210 · Longfian Scitech Co., Ltd. · Dec 2022
Portable Oxygen Concentrator, model: P2-E6
K210371 · Qingdao Kingon Medical Science and Technology Co., Ltd. · Jun 2022
Oxygen Concentrator
K202389 · Foshan Mic Medical Technology Co., Ltd. · Apr 2022
X-PLO2R
K203086 · Belluscura, LLC · Mar 2021
Invacare Perfecto2V Oxygen Concentrator
K200890 · Invacare Corporation · Aug 2020
Aer X
K200496 · 3B Medical, Inc. · Jul 2020